June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions
Author Affiliations & Notes
  • Stephanie Joachim
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Christine Mondon
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Sandra Kuehn
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Sabrina Reinehr
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Franz Grus
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Burkhard Dick
    Experimental Eye Research Institute, Ruhr University, Bochum, Germany
  • Footnotes
    Commercial Relationships Stephanie Joachim, None; Christine Mondon, None; Sandra Kuehn, None; Sabrina Reinehr, None; Franz Grus, None; Burkhard Dick, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 6110. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stephanie Joachim, Christine Mondon, Sandra Kuehn, Sabrina Reinehr, Franz Grus, Burkhard Dick; Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. Invest. Ophthalmol. Vis. Sci. 2013;54(15):6110.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Glaucoma is characterized by death of retinal ganglion cells (RGCs), but its cause is still unknown. Our studies indicate that immunization with ocular antigens leads to RGC loss in a model of Experimental Autoimmune Glaucoma. To gain further knowledge about the mechanism and time-course of RGC cell death caspase 3 levels and possible antibody appearances were evaluated in this model.

Methods: Lewis rats were immunized with a optic nerve homogenate in Freund’s adjuvant and pertussis toxin (ONA), while the control group was injected with sodium chloride (CO). RGC density was quantified via retinal whole mounts and caspase 3+ cells were evaluated on retina cross-sections at 8, 12, and 22 days. IgM and IgG antibody deposits and GFAP reactivity were detected at the same points in time.

Results: We detected no difference in caspase 3+ cells 8 days after immunization (p=0.23). At 14 days distinct IgM deposits were observed epiretinally in ONA animals and these animals had higher caspase 3+ rates (2.0±0.3) than controls (0.4±0.2; p=0.004). But both groups showed no difference in RGC density (p=0.62) at this time. At 22 days we detected a significantly higher number of apoptotic RGCs in ONA animals (ONA: 2.0±0; CO: 0.4±0.2; p=0.0007) and concurrent a lower RGC density (p=0.04). Regarding Ig deposits, 14 and 22 days after immunization we observed Igs in the ganglion cell layer (GCL) of ONA retinas. Especially 22 days after immunization we noted the IgG deposits are often in close vicinity to caspase+ cells in the GCL. The GFAP+ area in ONA retinas continuously increased. Already at 8 days ONA animals had a significantly higher mean GFAP+ area (7.2±0.5%) than CO (5.0±0.8%; p=0.02). Similar differences were noted at 14 days (CO=6.3±0.5%; ONA=7.1±1.0%; p=0.04). We observed the largest percentage of GFAP+ area in the ONA group (8.5±0.7%) at 22 days (CO: 6.1±0.6%; p=0.02).

Conclusions: Our data suggest that immunization with ocular antigens leads to apoptotic RGC death. Antibody deposits are detectable in the retina when apoptosis occurs. Therefore, we conclude that antibodies are engaged in eliciting RGC apoptosis in this animal model.

Keywords: 426 apoptosis/cell death • 555 immunomodulation/immunoregulation • 699 retinal glia  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×